VirtualScopics Provides Primary Endpoint in Cartilage Repair Clinical Trial

VirtualScopics, Inc. … announced that BioSyntech Inc., a Canadian medical device company based in Laval, Quebec, has reached its enrollment goal in the Canadian-European pivotal clinical trial for its cartilage repair device (BST-CarGel) and will now focus on quantitative measures to determine enhanced efficacy compared to the surgical technique called microfracture.
CNN Money